Skip to:
-

Diseases

We aim to improve the diagnosis, prevention and treatment of many diseases that place a significant burden on the Australian or global community.

Filter by technology & area

A

Allergy Anaemia Asthma Autoinflammatory diseases

B

Blood cancers Bowel cancer Brain cancer Breast cancer

C

Cancer Coeliac disease Coronavirus Cryptococcosis

D

Dementia Diabetes

E

Epilepsy

F

FSHD

G

Giardiasis

H

Hepatitis B HIV

I

Inflammatory bowel disease Influenza

L

Leukaemia Lung cancer Lupus Lymphoma

M

Malaria Melanoma Multiple sclerosis Myeloma Myeloproliferative disorders

N

Neurodegenerative disorders

O

Ovarian cancer

P

Pancreatic cancer Parkinson’s disease Primary immunodeficiency

R

Rare cancers Retinal disorders Rheumatic fever Rheumatoid arthritis

S

Scabies Stomach cancer

T

Toxoplasmosis Tuberculosis Type 1 diabetes Type 2 diabetes
Group photo in a laboratory including Dr Sarah Diepstraten, Dr Eddie La Marca, Associate Professor Gemma Kelly, Dr Yin Yuan.

Meet the team who have found a potential new treatment for a common type of blood cancer.

The combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML).

Learn more

Latest discoveries and insights 

High reward research: gene pathwaysthat may cause autoimmune disease
12 September 2024
Outstanding breast cancer researcher honoured 
09 September 2024
WEHI bioinformatician wins prestigious Eureka prize 
05 September 2024
Two-in-one breakthrough: Cutting-edge immunotherapy could hold promise for incurable brain cancer
02 September 2024
Historic win for pioneering breast cancer researchers  
28 August 2024
$66 million in 10 years: groundbreaking strategic investment fund to drive biomedical innovation
27 August 2024
More news
Sign up to our quarterly newsletter Illuminate

Find out about recent discoveries, community supporters and more.

Illuminate Winter 2024
View the current issue
© WEHI 2024
Close